Lv33
290 积分 2023-10-16 加入
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System
1天前
已完结
Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment
1天前
已完结
Pharmacovigilance insights into medication-induced risk of dural arteriovenous fistula
1天前
已完结
Post-Marketing Safety Surveillance of Adalimumab, Secukinumab, and Infliximab in Hidradenitis Suppurativa: An Analysis of the FDA Adverse Events Reporting System (FAERS) Database
1天前
已完结
The safety assessment of ustekinumab on psoriasis and psoriatic arthritis: A real-world analysis based on the FDA adverse event reporting system database
1天前
已完结
Reported Psychiatric Adverse Events Among Isotretinoin Users: Monitoring Priorities from a 20-Year FAERS Database Study
1天前
已完结
The real-world safety profile of sertraline: Pharmacovigilance analysis of the FAERS database
1天前
已完结
Characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated pemphigus patients: A retrospective analysis of 66 cases
1天前
求助中
EPR25-131: Hematologic Adverse Effects Profile of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Study Using FAERS Database
1天前
求助中
A disproportionality analysis of thromboembolic and cardiovascular adverse event signal strength across various JAK-inhibitors based on the FAERS database
1天前
已完结
皖公网安备34019202002308
